It is a multinational study investigating the safety and efficacy of biphasic insulin aspart 30/70 (BIAsp 30) in the routine management of patients with Type 2 diabetes mellitus. Five published ...

Clin Drug Invest. 2004;24(12):695-717.

We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.